Utilization of Drugs for Attention-Deficit Hyperactivity Disorder Among Young Patients in China, 2010–2019
Bibliographic Data
| ID | 15527032 |
|---|---|
| Authors | Zhiliang Wang (0000-0001-6587-820X, Shaoxing People's Hospital), Xiaoyan Wu (0000-0003-4098-1731, Shaoxing No.6 People's Hospital), Zhenwei Yu (0000-0002-3776-2290, Sir Run Run Shaw Hospital), Lingyan Yu (0000-0001-7828-139X, Second Affiliated Hospital of Zhejiang University, corresponding author) |
| Year | 2022 |
| Volume | 12 |
| Pages | 802489-802489 |
| Publication date | 2022-02-09 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2021.802489 |
| PMID | 35222107 |
| OpenAlex | W4211158247 |
| Language | EN |
| Citations received | 1 |
| References cited | 23 |
The use of ADHD drugs and the corresponding cost increased rapidly in China, and methylphenidate was the most frequently prescribed medicine. The increase in ADHD prescriptions requires attention to ensure that it reflects appropriate use, especially in patients aged 6-11 years
Atomoxetine · China · Medical prescription · Methylphenidate · Psychiatry · Attention Deficit Hyperactivity Disorder · Functional Brain Connectivity Studies · Medicine · Neural and Behavioral Psychology Studies · Pediatrics · Pharmacology
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |